| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP &Chief Financial Officer
3 companies
Foletta Mark G is a Director at DEXCOM INC with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 44 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2021 | AMN Amn Healthcare Services Inc | Director | Sell | 2,500 | $95.02 | $237,540.00 | -16.9% | +18.4% | +4.7% | |
| Nov 16, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $341.32 | $341,319.53 | -1.4% | - | - | |
| Oct 15, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $396.82 | $396,819.42 | -1.3% | - | - | |
| Sep 14, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $394.14 | $394,135.55 | -0.9% | - | - | |
| Mar 3, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $277.08 | $277,079.31 | -0.7% | - | - | |
| Feb 3, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $237.84 | $237,842.98 | -1.7% | - | - | |
| Jan 3, 2020 | DXCM Dexcom Inc | Director | Sell | 1,000 | $218.05 | $218,052.89 | -2.1% | - | - | |
| Dec 3, 2019 | DXCM Dexcom Inc | Director | Sell | 1,000 | $227.59 | $227,593.30 | -1.2% | - | - | |
| May 28, 2019 | FBRX Forte Biosciences, Inc. | EVP &Chief Financial Officer | Buy | 5,000 | $4.30 | $21,475.00 | +49.8% | - | - | |
| May 15, 2019 | DXCM Dexcom Inc | Director | Sell | 1,000 | $121.89 | $121,894.52 | -2.4% | - | - |